MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in GLUE — Monte Rosa Therapeutics, Inc.
CIK 928047
TORONTO, A6
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,643,423
+$1,192,197 QoQ
Shares Held
191,877
-8.5% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 193 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,655,634,902 across 242 Biotechnology names. GLUE ranks #45 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
554,085 | $275,230,642 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
893,795 | $269,059,108 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,955,733 | $145,662,993 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
539,037 | $129,891,745 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,988,121 | $105,749,602 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
147,961 | $92,259,601 | |
| 7 | RPRX |
Royalty Pharma plc
|
678,768 | $38,058,521 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
441,957 | $36,050,432 |
All Filings in GLUE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,643,423 | 191,877 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,451,226 | 209,801 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,111,688 | 134,674 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $877,218 | 118,383 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $540,460 | 119,836 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $544,304 | 117,307 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $814,839 | 117,412 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $624,748 | 117,877 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $384,131 | 102,709 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $726,763 | 103,087 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $590,667 | 104,543 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $500,760 | 104,543 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $715,941 | 104,517 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $804,317 | 103,250 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $785,732 | 103,250 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $844,361 | 103,349 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $1,004,761 | 103,905 | Shares | Defined | 2023-08-11 | |
| 2022-03-31 | $1,292,882 | 92,217 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||